{"transactions":[{"id":4618405,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T21:05:55.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2112,"price":156.22,"value":329936.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of PRSUs. No shares were sold."}],"balance_after":3281,"source":{"system":"sec-edgar","filing":"0001818524-26-000006","document":"wk-form4_1789506353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000181852426000006/wk-form4_1789506353.xml","form_type":"4"}},{"id":4618404,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-15T21:05:55.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":3914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was previously granted performance restricted stock units (PRSUs) that vest upon the achievement of certain performance metrics, the achievement of one of which was certified on September 11, 2026."}],"balance_after":5393,"source":{"system":"sec-edgar","filing":"0001818524-26-000006","document":"wk-form4_1789506353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000181852426000006/wk-form4_1789506353.xml","form_type":"4"}},{"id":750173,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-04T21:54:17.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":3212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU was granted to the Reporting Person on June 2, 2025. In accordance with the terms of the RSU, the award vested as to 3,212 shares on June 2, 2026, and will vest as to 3,212 shares on June 2, 2027, 3,211 shares on June 2, 2028, and 3,211 shares on June 2, 2029, subject to the terms and conditions of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU was granted to the Reporting Person on June 2, 2025. In accordance with the terms of the RSU, the award vested as to 3,212 shares on June 2, 2026, and will vest as to 3,212 shares on June 2, 2027, 3,211 shares on June 2, 2028, and 3,211 shares on June 2, 2029, subject to the terms and conditions of the award."}],"balance_after":9634,"derivative":{"underlying":"Common Stock","underlying_shares":3212},"source":{"system":"sec-edgar","filing":"0001818524-26-000004","document":"wk-form4_1780610055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000181852426000004/wk-form4_1780610055.xml","form_type":"4"}},{"id":750172,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-04T21:54:17.000Z","date":"2026-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1733,"price":154.84,"value":268337.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Neurocrine Biosciences, Inc. (the \"Company\" or \"Issuer\") to satisfy tax withholding requirements on vesting of restricted stock units (\"RSUs\"). No shares were sold."}],"balance_after":1479,"source":{"system":"sec-edgar","filing":"0001818524-26-000004","document":"wk-form4_1780610055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000181852426000004/wk-form4_1780610055.xml","form_type":"4"}},{"id":750171,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-04T21:54:17.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":3212,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3212,"source":{"system":"sec-edgar","filing":"0001818524-26-000004","document":"wk-form4_1780610055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000181852426000004/wk-form4_1780610055.xml","form_type":"4"}},{"id":902228,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-17T22:44:03.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":6285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030."}],"balance_after":6285,"derivative":{"underlying":"Common Stock","underlying_shares":6285},"source":{"system":"sec-edgar","filing":"0001818524-26-000002","document":"wk-form4_1771368237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000181852426000002/wk-form4_1771368237.xml","form_type":"4"}},{"id":902227,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-17T22:44:03.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":35827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter."}],"balance_after":35827,"derivative":{"exercise_price":124.12,"expiration_date":"2036-02-13","underlying":"Common Stock","underlying_shares":35827},"source":{"system":"sec-edgar","filing":"0001818524-26-000002","document":"wk-form4_1771368237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000181852426000002/wk-form4_1771368237.xml","form_type":"4"}},{"id":1123685,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-06-04T21:37:41.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":70101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on June 2, 2026 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter."}],"balance_after":70101,"derivative":{"exercise_price":124.56,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":70101},"source":{"system":"sec-edgar","filing":"0000914475-25-000146","document":"wk-form4_1749073054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000146/wk-form4_1749073054.xml","form_type":"4"}},{"id":1123684,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay Chandru","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-06-04T21:37:41.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":12846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units will vest annually at 25% of the units vesting on each of June 2, 2026, June 2, 2027, June 2, 2028, and June 2, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units will vest annually at 25% of the units vesting on each of June 2, 2026, June 2, 2027, June 2, 2028, and June 2, 2029."}],"balance_after":12846,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12846},"source":{"system":"sec-edgar","filing":"0000914475-25-000146","document":"wk-form4_1749073054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000146/wk-form4_1749073054.xml","form_type":"4"}},{"id":2394737,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T21:37:11.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 11, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":100000,"derivative":{"exercise_price":6.94,"expiration_date":"2032-02-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-22-004613","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000156761922004613/doc1.xml","form_type":"4"}},{"id":2394736,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-15T21:37:11.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 11 of each year, with the first 1/3rd vesting on February 11, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,500 RSUs."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001567619-22-004613","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000156761922004613/doc1.xml","form_type":"4"}},{"id":2770761,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T21:52:15.000Z","date":"2021-03-24","kind":"exercise","acquired":false,"shares":3995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on the first anniversary measured from June 17, 2019 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":182956,"derivative":{"exercise_price":7.4885,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":3995},"source":{"system":"sec-edgar","filing":"0001567619-21-007084","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000156761921007084/doc1.xml","form_type":"4"}},{"id":2770760,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-26T21:52:15.000Z","date":"2021-03-24","kind":"sale","acquired":false,"shares":3995,"price":30.1657,"value":120511.9715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $30.00 to $30.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-007084","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000156761921007084/doc1.xml","form_type":"4"}},{"id":2770759,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-26T21:52:15.000Z","date":"2021-03-24","kind":"exercise","acquired":true,"shares":3995,"price":7.4885,"value":29916.5575,"ownership":{"direct":true},"balance_after":3995,"source":{"system":"sec-edgar","filing":"0001567619-21-007084","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000156761921007084/doc1.xml","form_type":"4"}},{"id":2826912,"issuer":{"id":5011,"kind":"organization","name":"Annexon, Inc.","symbol":"ANNX"},"owners":[{"id":41469,"kind":"person","name":"Keswani Sanjay Chandru","position":1,"cik":"0001818524","reported_name":"Keswani Sanjay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T01:08:08.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 25, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":115000,"derivative":{"exercise_price":30.07,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001567619-21-005223","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818524/000156761921005223/doc1.xml","form_type":"4"}}]}